pharmaceutical industryBusinessMark Cuban Would Still Have Dinner With Donald TrumpStartups‘Uber for Getting Off Antidepressants’ Launches in the USBusinessBlocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective DrugSciencePatients Are Left With Few Options as GLP-1 Copycats DisappearBusinessEli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff DrugsBusinessTrump’s FDA Cuts Are Putting Drug Development at RiskScienceThe Ozempic Shortage Is OverThe Big StoryThe King of Ozempic Is Scared as HellScienceRFK Plans to Take on Big Pharma. It’s Easier Said Than DoneBusinessMark Cuban’s War on Drug Prices: ‘How Much Fucking Money Do I Need?’ScienceThe Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster DrugScienceThe Crackdown on Compounded GLP-1 Meds Has BegunThe Big StoryAfter Shark Tank, Mark Cuban Just Wants to Break Shit—Especially the Prescription Drug IndustryScienceThe FDA Just Rejected a Bid for MDMA to Treat PTSDScienceIt’s Shockingly Easy to Buy Off-Brand Ozempic Online, Even if You Don’t Need ItScienceA Pill That Kills Ticks Is a Promising New Weapon Against Lyme DiseaseScienceA Study at the Center of the Abortion Pill Battle Was Just RetractedScienceA Startup Has Unlocked a Way to Make Cheap InsulinScienceA Gel Injected Into the Scrotum Could Be the Next Male ContraceptiveThe Big StoryYou Know It’s a Placebo. So Why Does It Still Work?ScienceA Single Infusion of a Gene-Editing Treatment Lowered High CholesterolScienceWegovy Slashes the Risk of Heart Attack and Stroke in a Landmark TrialScienceThe FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic RivalScienceCovid Boosters Can’t Outpace New Mutations. Here’s Why They Still WorkMore Stories
.jpg)
